Header Logo

Connection

MINGXING TENG to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications MINGXING TENG has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
MINGXING TENG
Connection Strength
0.706
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug. J Med Chem. 2022 06 09; 65(11):7581-7594.
    View in: PubMed
    Score: 0.706
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.